Valeant planning to appoint new leader as CEO remains hospitalized
January 05, 2016 at 18:44 PM EST
Valeant Pharmaceuticals International Inc. is planning to appoint a new chief executive while its CEO, Michael Pearson, remains under hospital care, said people familiar with the matter.